Skip to content

Effect of Milrinonein treatment vasospasm in patients with ?subarachnoid hemorrhage

Effect of Milrinonein treatment vasospasm in patients with ?subarachnoid hemorrhage

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141209020258N82
Enrollment
32
Registered
2018-07-11
Start date
2017-10-29
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subarachnoid hemorrhage. Nontraumatic subarachnoid hemorrhage

Interventions

Intervention 1: Intervention group: During digital subtraction angiography, we inject 50 micrograms per kilogram melirinone is initially and in following 0.5 to 0.75 micrograms per kilogram per minute

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: both of gender Patients with subarachnoid hemorrhage and vasospasm

Exclusion criteria

Exclusion criteria: Dissatisfaction

Design outcomes

Primary

MeasureTime frame
Vasospasm. Timepoint: Before and after intervention. Method of measurement: TransCranial Doppler sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86132222003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026